An Open-Label, Positive Drug-Controlled, Parallel, Multicenter Phase II Clinical Trial of the Efficacy, Safety, and Pharmacokinetics of Flonoltinib Maleate Tablets in Patients With Intermediate to High-Risk Myelofibrosis
Latest Information Update: 15 Apr 2025
At a glance
- Drugs Flonoltinib maleate (Primary) ; Ruxolitinib
- Indications Myelofibrosis
- Focus Therapeutic Use
- Sponsors Chengdu Zenitar Biomedical Technology
Most Recent Events
- 17 Jun 2024 New trial record